← All trials
NCT03869190
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2019
- Primary completion
- Sep 30, 2020
- Completion date
- Aug 23, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 305
- Arms / groups
- 7 / —
- Source
- AACT · ingestion pipeline
Sponsors
- RocheLead sponsor
- Forty Seven, Inc.Collaborator
- TesaroCollaborator
- Seattle GeneticsCollaborator
- AstellasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.